# Progress Note 05 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Martin Luther (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE004-SYN-TD
- Date: 1527-09-22
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ottilie Brandt-Mensah, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Six-week review of Ménière disease, depression and the passed stone. **S**

## History of present illness

Professor Luther returns six weeks after the consultation. He has had one attack since then, of about two hours, ten days before his preventive visit, and none in the three weeks since. He keeps sodium down at home and has cut coffee to a cup a day. Between attacks he feels slightly unsteady when he turns quickly or walks in the dark. The MRI was done last week. The stone he passed nine days after his sick visit has been analyzed. He has taken hydrochlorothiazide and sertraline 50 mg daily; the loose stools on starting sertraline have settled. He has attended five therapy sessions and has begun to plan small pleasant activities each day. His sleep is better, and he has no thoughts of harming himself. **S**

| Element | Detail |
|---|---|
| Attacks | One two-hour attack in six weeks; none in the last three weeks |
| Balance | Slight unsteadiness on quick turns and in the dark |
| Medicines | Hydrochlorothiazide 25 mg; sertraline 50 mg for five weeks |
| Therapy | Five CBT sessions |
| Safety | No suicidal ideation |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Ears, nose, mouth, and throat | Positive | Tinnitus quieter; fullness only before the last attack |
| Neurological | Positive | Mild unsteadiness on quick turns; one headache without dizziness |
| Genitourinary | Negative | No flank pain or blood in the urine since the stone passed |
| Musculoskeletal | Negative | No joint pain or swelling |
| Psychiatric | Positive | Mood better; sleep seven hours; PHQ-9 10 |

5 systems reviewed. **S**

## Current medications

- Meclizine 25 mg tablet, one by mouth up to every 8 hours during a severe vertigo attack only, for no more than 3 days at a time **S**
- Hydrochlorothiazide 25 mg tablet, one by mouth each morning **S**
- Sertraline 50 mg tablet, one by mouth each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 122/78 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 85.1 kg; BMI 27.8 kg/m². All vital signs are synthetic.

Sodium: 136 mmol/L; Potassium: 3.7 mmol/L; Creatinine: 1 mg/dL; Glucose: 92 mg/dL; Calcium: 10 mg/dL; Uric acid: 7.4 mg/dL; eGFR: 96 mL/min/1.73 m²; PHQ-9: 10. All results are synthetic.

## Change since baseline

- Sodium: 140 mmol/L at baseline, 136 mmol/L at this visit **S**
- Potassium: 4.2 mmol/L at baseline, 3.7 mmol/L at this visit **S**
- Creatinine: 1.02 mg/dL at baseline, 1 mg/dL at this visit **S**
- Glucose: 94 mg/dL at baseline, 92 mg/dL at this visit **S**
- Calcium: 9.7 mg/dL at baseline, 10 mg/dL at this visit **S**
- Uric acid: 6.9 mg/dL at baseline, 7.4 mg/dL at this visit **S**
- eGFR: 94 mL/min/1.73 m² at baseline, 96 mL/min/1.73 m² at this visit **S**
- PHQ-9: 15 at baseline, 10 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Blood pressure 122/78, pulse 72; weight 85.1 kg |
| Neurological | No nystagmus; head impulse test normal; tandem gait slightly unsteady; Romberg steady on a firm surface, sways on foam with eyes closed |
| Abdomen | No costovertebral angle tenderness |
| Psychiatric | Brighter, reactive affect; no suicidal ideation |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Ménière disease of the left ear, improving** (H81.02). One shorter attack in six weeks on the salt limit and thiazide. The MRI shows no vestibular schwannoma or other lesion. Sodium 136, potassium 3.7 mmol/L and calcium 10.0 mg/dL on the thiazide with sertraline; uric acid 7.4 mg/dL, up from 6.9, as expected with a thiazide, without gout. The mild unsteadiness between attacks fits incomplete compensation in the left inner ear. **S**
   - Continue hydrochlorothiazide 25 mg and the salt limit.
   - Vestibular rehabilitation with a home program from a vestibular physical therapist.
   - Repeat audiogram at the next visit.
2. **Urinary stone disease** (Z87.442). The stone analysis shows calcium oxalate monohydrate (80 percent) with calcium phosphate (20 percent). Ultrasound shows no hydronephrosis and no remaining stones. With two stones he is a recurrent calcium stone former, so a 24-hour urine is indicated to guide prevention. **S**
   - 24-hour urine for volume, calcium, oxalate, citrate, sodium, uric acid and creatinine, on his usual diet, before the next visit.
   - Keep drinking enough to pass at least 2.5 liters of urine a day.
3. **Recurrent depression, improving** (F33.1). PHQ-9 10, from 15 at intake, after five weeks of sertraline 50 mg and five therapy sessions; not yet a 50 percent response. Sodium normal on the SSRI with the thiazide. **S**
   - Continue sertraline 50 mg and weekly therapy; consider 100 mg if the PHQ-9 is not clearly lower at the next visit.
   - Safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline and the clinic number confirmed.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Vertigo attack diary: number, duration, hearing, tinnitus, fullness, headache | Every visit | Completed today | One two-hour attack in six weeks, none in three weeks; one headache without vertigo; Dizziness Handicap Inventory 36 (Dizziness Handicap Inventory in the notes; no LOINC code used) |
| Imaging | MRI of the internal auditory canals with gadolinium | Once, to exclude a retrocochlear lesion with asymmetric hearing loss | Completed today | No vestibular schwannoma or other lesion |
| Laboratory | Sodium, potassium, creatinine and calcium on a thiazide with an SSRI | Two to four weeks after starting, then every three to six months | Completed today | Sodium 137 and potassium 3.9 mmol/L two weeks after starting, drawn at the sick visit; today sodium 136, potassium 3.7 mmol/L, creatinine 1.0 mg/dL, calcium 10.0 mg/dL, glucose 92 mg/dL |
| Laboratory | Uric acid on a thiazide in a stone former | Baseline, then with the 24-hour urine | Completed today | 7.4 mg/dL, from 6.9; no gout |
| Examination | Balance between attacks | Every visit | Completed today | Mild unsteadiness on tandem gait and on foam with eyes closed |
| Referral | Vestibular rehabilitation for chronic imbalance | When imbalance persists between attacks | Referred | Referred to a vestibular physical therapist today |
| Medication safety | Vestibular suppressant use | Every visit | Completed today | One meclizine dose in six weeks |
| Self-management | Sodium, caffeine and alcohol limits | Every visit | Completed today | Salt cut at home, not when dining out; one coffee a day; beer unchanged |
| Imaging | Renal ultrasound after stone passage | Once after passage | Completed today | No hydronephrosis and no remaining stones |
| Laboratory | Stone analysis | Each stone retrieved | Completed today | Calcium oxalate monohydrate 80 percent, calcium phosphate 20 percent (reported in text; no observation stored) |
| Laboratory | 24-hour urine for a recurrent stone former | About six weeks after the stone passed; then within six months of starting treatment | Ordered | Kit given; to be collected before the next visit |
| Survey | PHQ-9 | At least monthly during acute treatment | Completed today | 10, from 15 at intake |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9) | Every visit | Completed today | No suicidal ideation, intent or plan; PHQ-9 item 9 scored 0. Safety plan reviewed |
| Medication safety | SSRI tolerability check two weeks after starting | 2 weeks after starting and after each dose change | Completed today | Done at the sick visit two weeks after starting and at the preventive visit: loose stools for a few days only; no activation |
| Self-management | Psychotherapy attendance | Weekly | Completed today | Five CBT sessions attended |

## Goal progress

- Fewer and milder vertigo attacks: no more than one disabling attack a month by three months, and able to preach without fear of an attack. In progress; target 1527-10-27. **S**
- Depression response (PHQ-9 down by at least 50 percent) by three months. In progress; target 1527-10-27. **S**
- Sodium intake below 2,300 mg a day. In progress; target 1528-01-31. **S**
- Urine volume of at least 2.5 liters a day. In progress; target 1528-01-31. **S**

## Guideline basis

- Clinical Practice Guideline: Ménière's Disease (2020), American Academy of Otolaryngology-Head and Neck Surgery Foundation (Basura GJ, et al. Otolaryngol Head Neck Surg 2020;162(2 Suppl):S1-S55)
- Medical Management of Kidney Stones: AUA Guideline (2014), American Urological Association (Pearle MS, et al. J Urol 2014;192(2):316-324)
- Surgical Management of Stones: American Urological Association/Endourological Society Guideline, Part I (2016), American Urological Association (Assimos D, et al. J Urol 2016;196(4):1153-1160)
- Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019), American Psychological Association
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense

## Follow-up

- 24-hour urine before the next visit. Review in five weeks with a repeat audiogram. **S**
- Next scheduled visit 1527-10-27: thirteen-week review: attacks, repeat audiogram, mood, and the 24-hour urine for stone prevention. **S**
